Filter
2711
Filtered Results: 2711
Text search:
regulatory
control
Featured
Recommendations
239
New Publications
715
Language
Document type
No document type
1282
Studies & Reports
494
Guidelines
477
Manuals
180
Strategic & Response Plan
156
Fact sheets
62
Training Material
22
Situation Updates
22
Resource Platforms
6
Brochures
5
Infographics
3
Online Courses
2
Countries / Regions
Global
118
Kenya
101
India
91
Ethiopia
58
Nigeria
56
Latin America and the Carribbean
53
Sierra Leone
49
Western and Central Europe
49
South Africa
46
Uganda
46
Liberia
43
Ghana
42
Africa
41
Zambia
37
Tanzania
34
Nepal
33
Bangladesh
32
Namibia
31
Rwanda
28
Myanmar / Burma
28
Ukraine
27
Malawi
25
West and Central Africa
24
South–East Asia Region
24
East and Southern Africa
24
Syria
21
Philippines
21
Eastern Europe
20
Lesotho
19
Middle East and North Africa
18
Paraguay
18
Guinea
14
Zimbabwe
13
Cambodia
12
Asia
12
El Salvador
11
Mozambique
11
Congo, Democratic Republic of
11
Eastern Europe and Central Asia
11
Botswana
11
Argentina
10
Eswatini/ Swaziland
10
Western Pacific Region
9
Russia
9
South Sudan
9
Indonesia
9
Senegal
8
Cameroon
7
Brazil
7
Pakistan
7
Chile
6
USA
6
North America
6
Bolivia
6
Yemen
6
Colombia
5
Burkina Faso
5
Haiti
5
Venezuela
5
Spain
5
Moldova
5
Sudan
5
Tajikistan
4
Thailand
4
Albania
4
Jordan
4
Germany
4
Georgia
4
Angola
4
Chad
4
Somalia
4
Ecuador
4
Benin
3
Laos
3
Afghanistan
3
Peru
3
Guinea-Bissau
3
United Kingdom
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Gambia
2
Kazakhstan
2
Iran
2
Saudi Arabia
2
Turkmenistan
2
Bosnia and Herzegovina
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Honduras
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Guatemala
2
Turkey
1
Australia
1
Togo
1
China
1
Fiji
1
Kyrgyzstan
1
Niger
1
Uzbekistan
1
Burundi
1
Morocco
1
Qatar
1
Mauritania
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Libya
1
Authors & Publishers
Publication Years
Category
Countries
1018
Clinical Guidelines
188
Public Health
180
Key Resources
150
Women & Child Health
94
Pharmacy & Technologies
70
Capacity Building
24
Toolboxes
COVID-19
274
AMR
177
HIV
168
TB
137
Pharmacy
119
Mental Health
118
Planetary Health
110
Rapid Response
100
Caregiver
92
NTDs
67
NCDs
58
Ebola & Marburg
54
Malaria
50
Global Health Education
46
Conflict
42
Health Financing Toolbox
38
Specific Hazards
35
Disability
31
Refugee
29
Natural Hazards
22
Zika
20
Polio
17
Cholera
9
Social Ethics
9
Compilation of country case studies and best practices. World Health Report (2010) Background Paper, 25
In the last three decades, health financialization has surged in
several creative ways, yet this growing phenomenon remains surprisingly
unknown, and neglected, in the global health arena. Financialization in the
health domain could be described as the uncontrolled expansion of finance along vari...
The key tools and governance approaches for
international cooperation for sustainable development
(hereafter, international cooperation) were set up in a
markedly different time and age. International
cooperation – with official development assistance
(ODA) as the dominant means of implementa...
Achieving financial risk protection for the whole population requires significant financing for health. Health systems in low- and middle-income countries (LMIC) are plagued with persistent underfunding, and recent reductions in official development assistance have been registered. To create fiscal
...
Development assistance for health (DAH)
plays a vital role in supporting health programmes in lowand middle-income countries. While DAH has historically
focused on infectious diseases and maternal and child
health, there is a lack of comprehensive analysis of DAH
trends, strategic shifts and the...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
This comprehensive HPFM report thoroughly explores Kenya’s health financing landscape. It provides an in-depth analysis of the current state of affairs and sheds light on required strategic changes in health financing. The report points out the need to improve public financial management within th...
For this report, the Task Force commissioned
additional background papers on health taxes to
update the evidence, assess short-term revenue
potential, and understand the role of health taxes
in the current era of multiple crises. We find that
health taxes continue to be underutilized despite th...
This Guide is part of WHO’s overall programme of work on Political Economy of Health Financing Reform: Analysis and Strategy to Support UHC. The impetus for this work came from demands for more concrete evidence, recognition and integration of political economy issues within
health financing, and...
In 2022, Namibia had an estimated population of 2.6 million people, where 51 per cent per cent are females and 52.5 per cent of households in urban areas, with fast-growing urban informal settlements which lack access to basic services. Namibia has a young population; 42 per cent are children (0-17 ...
The Regional Child Protection Operational Note has been developed by IOM and UNICEF’s Regional and Country Offices in North, West and Central Africa as a collaborative inter-agency and cross-regional endeavour within the framework of the sixth phase of the IOM Regional Development and Protection P...
Meeting report, Kampala, Uganda,
7–8 November 2023
Two malaria vaccines are currently WHO prequalified and recommended1 for use to prevent
P. falciparum malaria in young children, the RTS,S/AS01 vaccine, currently manufactured by
GlaxoSmithKline (GSK), and the R21/Matrix-M vaccine, manufactured by Serum Institute of India
Pvt (SII)
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
This publication is intended for professionals training or practicing in mental health and not for the general public. The opinions
expressed are those of the authors and do not necessarily represent the views of the Editor or IACAPAP. This publication seeks to
describe the best treatments and pra...
Accessed Febr. 6 ,2020
With this quick reference guide, providers can easily recognize diseases and side effects related to climate change, implement appropriate management and provide guidance to exposed populations, provide up-to-date information on the relationship between the adverse effects of certain drugs and the w...
